Difolin+, 30 kapsulių

Hemoglobinui    Energijai    Nervams ir imunitetui

13.47€ 2už1 kainą!

Maisto papildas geležies trūkumui, nuovargiui, energijai, hemoglobinui.

Difolin+, 30 kapsulių (13,2g)

Maisto papildas geležies trūkumui, nuovargiui, energijai, hemoglobinui

 

Neturi geležies poskonio, neturi sąveikos su maistu, gerai toleruojama.

Energijos apykaitai. Geležis, vitaminas C ir B₁₂ palaiko normalią energijos apykaitą.

Nuovargiui, pavargimo jausmui.

Hemoglobinui. Geležis, vitaminas B₁₂- padeda palaikyti raudonųjų kraujo kūnelių susidarymą, geležis- normalų hemoglobino susidarymą, foliatai- kraujodarą.

 

“Difolin+” – moters gerai savijautai: geležies įsisavinimui, hemoglobinui, nuovargio mažinimui, nervams, imunitetui: mikrokapsuliuota liposomose geležis + folio rūgštis + vitaminai B12, D3, C + varis.

✓ Geležis, folio rūgštis, vitaminas B12 – vieni iš būtiniausių kraujo gamybai elementų – geležis ir vitaminas B12 padeda palaikyti normalų raudonųjų kraujo kūnelių susidarymą, geležis – normalų hemoglobino susidarymą, foliatai – normalią kraujodarą.
✓ Varis padeda palaikyti normalų geležies pernešimą organizme.
✓ Vitaminas C gerina geležies įsisavinimą iš maisto.
✓ Vitaminas D svarbus daugeliui organizmo procesų, pvz. padeda palaikyti normalią imuninės sistemos veiklą, kaulų bei dantų būklę.

 

Difolin+ sudėtyje naudojama mikrokapsuliuota liposomose geležis, kuri organizme efektyviai pasisavinama, neturi geležies poskonio, nedirgina virškinamojo trakto, neturi sąveikos su maistu (kava, arbata, pieno produktais).

Taip pat geležis, varis, vitaminai C ir B12 padeda palaikyti normalią energijos apykaitą.

Varis, vitaminai C ir B12 padeda palaikyti normalią nervų sistemos veiklą.

Foliatai, vitaminai C ir B12 padeda palaikyti normalią psichologinę funkciją, o foliatai, geležis, vitaminai C ir B12 padeda mažinti pavargimo jausmą ir nuovargį.

Geležis naudinga normaliai vaikų pažintinei raidai.

 

Laikymas. Laikyti sausoje, vaikams nepasiekiamoje vietoje.

Gamintojas: Valentis AG, CH-6982 Agno-Lugano, Šveicarija.
Platintojas: UAB „Valentis Baltic“, Molėtų pl. 11, LT-08409 Vilnius, Lietuva. Pagaminta ES.

Vienoje kapsulėjeRMV*
Vitaminas C100 mg125 %
Geležis21 mg150 %
Varis1 mg100 %
Folio rūgštis400 μg200 %
Vitaminas D325 μg (1000 TV)500 %
Vitaminas B1210 μg400 %
*RMV - Referencinė maistinė vertė

Sudedamosios dalys:

Emulsiklis – mikrokristalinė celiuliozė, natrio L-askorbatas (vitaminas C), kapsulės apvalkalas (stabilizatorius – hidroksipropilmetilceliuliozė, dažiklis – kalcio karbonatas, vanduo), liposominė geležis (kukurūzų krakmolas, geležies difosfatas (geležies pirofosfatas), emulsiklis – saulėgražų lecitinas), cholekalciferolis (vitaminas D3), cianokobalaminas (vitaminas B12), lipnumą reguliuojančios medžiagos – riebalų rūgščių magnio druskos ir silicio dioksidas, vario gliukonatas, pteroilmonoglutamo rūgštis (folio rūgštis).

Rekomenduojama suaugusiesiems ir vaikams nuo 12 metų, ypač planuojančioms pastoti, nėščioms ir maitinančioms moterims, gerti po 1 kapsulę per dieną, jei Jūsų gydytojas nepaskyrė kitaip, ryte pusvalandį prieš valgį užgeriant stikline vandens.

 

 

Įspėjimai:

Labai svarbu įvairi ir subalansuota mityba bei sveikas gyvenimo būdas. Neviršyti nustatytos rekomenduojamos dozės. Maisto papildas neturėtų būti vartojamas kaip maisto pakaitalas.

Laikyti tamsioje, sausoje vietoje, ne aukštesnėje kaip 25 °C temperatūroje, vaikams nepasiekiamoje vietoje.

Literatūros sąrašas
  1. European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of a health claim related to increasing maternal folate status by supplemental folate intake and reduced risk of neural tube defects pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA Journal 2013;11(7):3328.
  2. European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of health claims related to folate and blood formation (ID 79), homocysteine metabolism (ID 80), energy-yielding metabolism (ID 90), function of the immune system (ID 91), function of blood vessels (ID 94, 175, 192), cell division (ID 193), and maternal tissue growth during pregnancy (ID 2882) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2009; 7(9):1213.
  3. European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of health claims related to folate and contribution to normal psychological functions (ID 81, 85, 86, 88), maintenance of normal vision (ID 83, 87), reduction of tiredness and fatigue (ID 84), cell division (ID 195, 2881) and contribution to normal amino acid synthesis (ID 195, 2881) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2010;8(10):1760.
  4. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014. Scientific opinion on Dietary Reference Values for folate. EFSA Journal 2014;12(11):3893.
  5. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002 Oct 23-30;288(16):2015-22.
  6. Gilbody S, Lightfoot T, Sheldon T. Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity. J Epidemiol Community Health 2007;61:631–637.
  7. Yang HT, Lee M, Hong KS, Ovbiagele B and Saver JL, Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials. European Journal of Internal Medicine, 2012; 23(8), 745-754.
  8. COI and FSA. Health and Lifestyle in Pregnancy. Folic Acid. Qualitative Research. Final Report, 2007. COI Ref: 276285 (Define ref: 1567).
  9. National Center on Birth Defects and Developmental Disabilities. Neural Tube Defects (Annual Report), 2012. US Centers for Disease Control and Prevention.
  10. Walker JG, Batterham PJ, Mackinnon AJ, Jorm AF, Hickie I, Fenech M, et al. Oral folic acid and vitamin B-12 supplementation to prevent cognitive decline in community-dwelling older adults with depressive symptoms–the Beyond Ageing Project: a randomized controlled trial. Am J Clin Nutr. 2012; 95(1): 194-203.
  11. Scholl TO, Johnson WG Folic acid: influence on the outcome of pregnancy. Am J Clin Nutr. 2000; 71(5 Suppl): 1295S-1303S.
  12. Barzda A. et al. Suaugusių Lietuvos žmonių faktinės mitybos tyrimas ir vertinimas. Medicinos teorija ir praktika 2009; 15(1):53-58.
  13. Holick MF. Vitamin D Deficiency. The New England Journal of Medicine. 2007; 357:266-81.
  14. Pludowski P. et al. Practical guidelines for the supplementation of vitamin D and treatment of deficits in Central Europe. Endocrinologia Polska 2013; 64(4):319-327.
  15. Kull Jr M, Kallikorm R, Tamm A, Lember M. Seasonal variance of 25-(OH) vitamin D in the general population of Estonia, a Northern European country.
  16. Hollis BW, Wagner CL. Vitamin D requirements during lactation: high-dose maternal supplementation as therapy to prevent hypovitaminosis D for both the mother and the nursing infant. Am J Clin Nutr 2004;80:Suppl 6:1752S-1758S.
  17. European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA) (2010). “Scientific opinion on the substantiation of health claims related to vitamin D and normal function of the immune system and inflammatory response (ID 154, 159), maintenance of normal muscle function (ID 155) and maintenance of normal cardiovascular function (ID 159) pursuant to Article 13(1) of Regulation (EC) No 1924/2006”. EFSA Journal 2010; 8(2):1468.
  18. European Food Safety Authority (EFSA) Scientific opinion of the Panel on Dietetic Products, Nutrition and Allergies (NDA). “Scientific Opinion on the substantiation of health claims related to vitamin D and maintenance of bone and teeth (ID 150, 151, 158), absorption and utilisation of calcium and phosphorus and maintenance of normal blood calcium concentrations (ID 152, 157), cell division (ID 153), and thyroid function (ID 156) pursuant to Article 13(1) of Regulation (EC) No 1924/2006”. EFSA Journal 2009; 7(9):1227.
  19. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the Tolerable Upper Intake Level of vitamin D. EFSA Journal 2012;10(7):2813.
  20. Davidsson L, Walczyk T, Morris A, Hurrell RF. Influence of ascorbic acid on iron absorption from an iron-fortified, chocolate-flavored milk drink in Jamaican children. Am J Clin Nutr. 1998 May;67(5):873-7.
  21. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2009. Scientific Opinion on the substantiation of health claims related to iron and formation of red blood cells and haemoglobin (ID 249, ID 1589), oxygen transport (ID 250, ID 254, ID 256), energy-yielding metabolism (ID 251, ID 1589), function of the immune system (ID 252, ID 259), cognitive function (ID 253) and cell division (ID 368) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2009;7(9):1215.
  22. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2010. Scientific Opinion on the substantiation of health claims related to iron and formation of red blood cells and haemoglobin (ID 374, 2889), oxygen transport (ID 255), contribution to normal energy-yielding metabolism (ID 255), reduction of tiredness and fatigue (ID 255, 374, 2889), biotransformation of xenobiotic substances (ID 258), and “activity of heart, liver and muscles” (ID 397) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2010;8(10):1740.
  23. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014. Scientific Opinion on the substantiation of a health claim related to vitamin C and increasing non-haem iron absorption pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA Journal 2014;12(1):3514.
  24. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2015. Scientific Opinion on Dietary Reference Values for iron. EFSA Journal 2015;13(10):4254.
  25. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2016. Scientific opinion on iron and contribution to the normal function of the immune system: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA Journal 2016;14(7):4548.
  26. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to vitamin B6 and protein and glycogen metabolism (ID 65, 70, 71), function of the nervous system (ID 66), red blood cell formation (ID 67, 72, 186), function of the immune system (ID 68), regulation of hormonal activity (ID 69) and mental performance (ID 185) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 on request from the European Commission. EFSA Journal 2009; 7(9):1225.
  27. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of health claims related to vitamin B6 and contribution to normal homocysteine metabolism (ID 73, 76, 199), maintenance of normal bone (ID 74), maintenance of normal teeth (ID 74), maintenance of normal hair (ID 74), maintenance of normal skin (ID 74), maintenance of normal nails (ID 74), contribution to normal energy-yielding metabolism (ID 75, 214), contribution to normal psychological functions (ID 77), reduction of tiredness and fatigue (ID 78), and contribution to normal cysteine synthesis (ID 4283) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2010;8(10):1759.
  28. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific opinion on the substantiation of health claims related to vitamin B12 and red blood cell formation (ID 92, 101), cell division (ID 93), energy-yielding metabolism (ID 99, 190) and function of the immune system (ID 107) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 on request from the European Commission. EFSA Journal 2009; 7(9): 1223.
  29. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to vitamin B12 and contribution to normal neurological and psychological functions (ID 95, 97, 98, 100, 102, 109), contribution to normal homocysteine metabolism (ID 96, 103, 106), maintenance of normal bone (ID 104), maintenance of normal teeth (ID 104), maintenance of normal hair (ID 104), maintenance of normal skin (ID 104), maintenance of normal nails (ID 104), reduction of tiredness and fatigue (ID 108), and cell division (ID 212) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2010;8(10):1756.
  30. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to vitamin C and protection of DNA, proteins and lipids from oxidative damage (ID 129, 138, 143, 148), antioxidant function of lutein (ID 146), maintenance of vision (ID 141, 142), collagen formation (ID 130, 131, 136, 137, 149), function of the nervous system (ID 133), function of the immune system (ID 134), function of the immune system during and after extreme physical exercise (ID 144), non-haem iron absorption (ID 132, 147), energy yielding metabolism (ID 135), and relief in case of irritation in the upper respiratory tract (ID 1714, 1715) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 on request from the European Commission. EFSA Journal 2009; 7(9):1226.
  31. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2013. Scientific Opinion on Dietary Reference Values for vitamin C. EFSA Journal 2013;11(11):3418.
  32. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014. Scientific Opinion on the substantiation of a health claim related to vitamin C and increasing non-haem iron absorption pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA Journal 2014;12(1):3514.
  33. Fidler MC, Walczyk T, Davidsson L, Zeder C, Sakaguchi N, Juneja LR, Hurrell RF. A micronised, dispersible ferric pyrophosphate with high relative bioavailability in man. Br J Nutr. 2004 Jan;91(1):107-12.
  34. Harrington M, Hotz C, Zeder C, Polvo GO, Villalpando S, Zimmermann MB, Walczyk T, Rivera JA, Hurrell RF. A comparison of the bioavailability of ferrous fumarate and ferrous sulfate in non-anemic Mexican women and children consuming a sweetened maize and milk drink. Eur J Clin Nutr. 2011 Jan;65(1):20-5. doi: 10.1038/ejcn.2010.185. Epub 2010 Sep 15.
  35. IoM (Institute of Medicine), 2000. Dietary Reference Intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin and cholin. National Academy Press, Washington, D.C.
  36. Moretti D, Zimmermann MB, Wegmuller R, Walczyk T, Zeder C, Hurrell RF Iron status and food matrix strongly affect the relative bioavailability of ferric pyrophosphate in humans. Am J Clin Nutr. 2006; 83, 632–38.
  37. Ordway GA, Garry DJ. Myoglobin: an essential hemoprotein in striated muscle. J Exp Biol. 2004 Sep;207(Pt 20):3441-6.
  38. Pisani A, Riccio E, Sabbatini M, Andreucci M, Del Rio A, Visciano B. Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial. Nephrol Dial Transplant. 2015 Apr;30(4):645-52. doi: 10.1093/ndt/gfu357. Epub 2014 Nov 13.
  39. Shade CW. Liposomes as Advanced Delivery Systems for Nutraceuticals. Integr Med (Encinitas). 2016 Mar;15(1):33-6.
  40. Thankachan P, Walczyk T, Muthayya S, Kurpad AV, Hurrell RF. Iron absorption in young Indian women: the interaction of iron status with the influence of tea and ascorbic acid. Am J Clin Nutr. 2008 Apr;87(4):881-6.
  41. Xu Z, Liu S, Wang H, Gao G, Yu P, Chang Y. Encapsulation of iron in liposomes significantly improved the efficiency of iron supplementation in strenuously exercised rats. Biol Trace Elem Res. 2014 Dec;162(1-3):181-8.
  42. Baik HW, Russell RM. Vitamin B12 deficiency in the elderly. Annu Rev Nutr. 1999;19:357-77.
  43. Clarke R, Birks J, Nexo E, Ueland PM, Schneede J, Scott J, Molloy A, Evans JG. Low vitamin B-12 status and risk of cognitive decline in older adults. Am J Clin Nutr. 2007 Nov;86(5):1384-91.
  44. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific opinion on the substantiation of health claims related to vitamin B12 and red blood cell formation (ID 92, 101), cell division (ID 93), energy-yielding metabolism (ID 99, 190) and function of the immune system (ID 107) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 on request from the European Commission. EFSA Journal 2009; 7(9): 1223.
  45. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to vitamin B12 and contribution to normal neurological and psychological functions (ID 95, 97, 98, 100, 102, 109), contribution to normal homocysteine metabolism (ID 96, 103, 106), maintenance of normal bone (ID 104), maintenance of normal teeth (ID 104), maintenance of normal hair (ID 104), maintenance of normal skin (ID 104), maintenance of normal nails (ID 104), reduction of tiredness and fatigue (ID 108), and cell division (ID 212) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2010;8(10):1756.
  46. EFSA Scientific Committee on Food. Scientific Panel on Dietetic Products, Nutrition and Allergies. Tolerable upper intake levels for vitamins and minerals. February 2006.
  47. Ho C, Kauwell GP, Bailey LB. Practitioners’ guide to meeting the vitamin B-12 recommended dietary allowance for people aged 51 years and older. J Am Diet Assoc. 1999 Jun;99(6):725-7.
  48. IoM (Institute of Medicine), 2000. Dietary Reference Intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin and cholin. National Academy Press, Washington, D.C.
  49. Köbe T, Witte AV, Schnelle A, Grittner U, Tesky VA, Pantel J, Schuchardt JP, Hahn A, Bohlken J, Rujescu D, Flöel A. Vitamin B-12 concentration, memory performance, and hippocampal structure in patients with mild cognitive impairment. Am J Clin Nutr ajcn116970.
  50. Kozyraki R, Cases O. Vitamin B12 absorption: mammalian physiology and acquired and inherited disorders. Biochimie. 2013 May;95(5):1002-7.
  51. Schjønsby H. Vitamin B12 absorption and malabsorption. Gut. 1989 Dec; 30(12): 1686–1691.
  52. European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the substantiation of health claims related to copper and protection of DNA, proteins and lipids from oxidative damage (ID 263, 1726), function of the immune system (ID 264), maintenance of connective tissues (ID 265, 271, 1722), energy-yielding metabolism (ID 266), function of the nervous system (ID 267), maintenance of skin and hair pigmentation (ID 268, 1724), iron transport (ID 269, 270, 1727), cholesterol metabolism (ID 369), and glucose metabolism (ID 369) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2009; 7(9):1211

Kur įsigyti

Difolin ir Difolin+ maisto papildų gerai moters savijautai teiraukimės visose vaistinėse!

Turite klausimų?